Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.77 |
| ▸ | ACE | P12821 | 3/20 | 0.72 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.69 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.69 |
| ▸ | ITGAL | P20701 | 3/20 | 0.69 |
| ▸ | TACR1 | P25103 | 1/20 | 0.68 |
| ▸ | ECE1 | P42892 | 6/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | APAF1 | O14727 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | FPR2 | P25090 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetyltryptophan SCHEMBL57141 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL29360698 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL29401158 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL702442 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL4216450 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL4216452 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL57140 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL23933298 | 0.97 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL1427071 | 0.97 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL1304483 | 0.97 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4139438-A1 | COMPOSITIONS FOR PRESERVATION OF VIRAL VECTORS | Cellular Biomedicine Group Inc. (US) | 2023-03-01 | — | — | EP | disclosed |
| EP-1669065-B1 | DRUG CONTAINING (2R)-2-PROPYLOCTANOIC ACID AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO (JP) | 2012-07-18 | — | — | EP | disclosed |
| US-8053599-B2 | Drug containing (2R)-2-propyloctanoic acid as the active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20070105956-A1 | Drug containing (2r)-2-propyloctanoic acid as the active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070066686-A1 | Infusion preparation containing (2r)-2-propyloctanoic acid as at the active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-1669065-A1 | DRUG CONTAINING (2R)-2-PROPYLOCTANOIC ACID AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-06-14 | — | — | EP | disclosed |
| EP-1669066-A1 | INFUSION PREPARATION CONTAINING (2R)-2-PROPYLOCTANOIC ACID AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105956-A1 | Drug containing (2r)-2-propyloctanoic acid as the active ingredient | PSEN2, PRNP, GRIK5 | ALOX15 74/4885ACE 1292/4885ITGB2 3855/4885 |
| US-20070066686-A1 | Infusion preparation containing (2r)-2-propyloctanoic acid as at the active ingredient | PARK7, IDE, ATP6V1B2 | ALOX15 19/4885ACE 1990/4885ITGB2 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.